Boston Heart Diagnostics Corporation
Scott Madel serves as President of Boston Heart Diagnostics, driving innovations in cardiovascular disease treatment through advanced diagnostics and personalized health programs since January 2022. Concurrently, Scott holds the position of Executive Director at The Brahman Group, offering consulting and advisory services to life sciences and private equity sectors. Previously, Scott was the Chief Executive Officer at BioHealth Diagnostics, overseeing clinical laboratory operations, and held multiple leadership roles at Genova Diagnostics, including CEO and Vice President of Business Development, playing a key part in global market strategies and operations. Scott's career includes strategic positions at Novartis Pharmaceuticals and Merck, alongside foundational roles in sales and nursing. Educational accomplishments include dual MBA degrees in Business Intelligence and an ongoing MBA at D'Amore-McKim School of Business, complemented by a BS in Medical Microbiology and Immunology from the University of Wisconsin-Madison.